| Prolonged inflammation leads to ongoing damage after spinal cord injury JM Kwiecien, W Dabrowski, B Dąbrowska-Bouta, G Sulkowski, W Oakden, ... PloS one 15 (3), e0226584, 2020 | 99 | 2020 |
| Local serpin treatment via chitosan-collagen hydrogel after spinal cord injury reduces tissue damage and improves neurologic function JM Kwiecien, L Zhang, JR Yaron, LN Schutz, CJ Kwiecien-Delaney, ... Journal of clinical medicine 9 (4), 1221, 2020 | 26 | 2020 |
| Myxoma virus derived immune modulating proteins, M-T7 and Serp-1, reduce early inflammation after spinal cord injury in the rat model JM Kwiecien, W Dabrowski, B Marzec-Kotarska, CJ Kwiecien-Delaney, ... Folia Neuropathologica 57 (1), 41-50, 2019 | 23 | 2019 |
| Deriving immune modulating drugs from viruses—a new class of biologics JR Yaron, L Zhang, Q Guo, M Burgin, LN Schutz, E Awo, L Wise, ... Journal of Clinical Medicine 9 (4), 972, 2020 | 22 | 2020 |
| Serine proteases and chemokines in neurotrauma: new targets for immune modulating therapeutics in spinal cord injury RN Beladi, KS Varkoly, L Schutz, L Zhang, JR Yaron, Q Guo, M Burgin, ... Current Neuropharmacology 19 (11), 1835, 2021 | 11 | 2021 |
| PEGylated serp-1 markedly reduces pristane-induced experimental diffuse alveolar hemorrhage, altering uPAR distribution, and macrophage invasion Q Guo, JR Yaron, JW Wallen III, KF Browder, R Boyd, TL Olson, M Burgin, ... Frontiers in Cardiovascular Medicine 8, 633212, 2021 | 11 | 2021 |
| Recombinant Myxoma Virus-Derived Immune Modulator M-T7 Accelerates Cutaneous Wound Healing and Improves Tissue Remodeling JR Yaron, L Zhang, Q Guo, EA Awo, M Burgin, LN Schutz, N Zhang, ... Pharmaceutics 12 (11), 1003, 2020 | 11 | 2020 |
| Local chitosan-serpin injection after spinal cord injury reduces inflammatory damage and improves neurologic function JM Kwiecien, L Zhang, JR Yaron, LN Schutz, CJ Kwiecien-Delaney, ... J. Clin. Med 9, 1221, 2020 | 5 | 2020 |
| Topical Application of Virus-Derived Immunomodulating Proteins and Peptides to Promote Wound Healing in Mouse Models L Zhang, JR Yaron, Q Guo, J Kilbourne, EA Awo, M Burgin, LN Schutz, ... Viruses as Therapeutics: Methods and Protocols, 217-226, 2021 | 3 | 2021 |
| Preclinical testing of viral therapeutic efficacy in pristane-induced lupus nephritis and diffuse alveolar hemorrhage mouse models Q Guo, L Zhang, JR Yaron, M Burgin, LN Schutz, EA Awo, AR Lucas Viruses as Therapeutics: Methods and Protocols, 241-255, 2021 | 2 | 2021 |
| Deriving Immune-Modulating Peptides from Viral Serine Protease Inhibitors (Serpins) JR Yaron, L Zhang, M Burgin, LN Schutz, EA Awo, S Keinan, G McFadden, ... Viruses as Therapeutics: Methods and Protocols, 107-123, 2021 | 1 | 2021 |
| Targeting Urokinase-Type Plasminogen Activator (uPA) and the uPA Receptor, Reduces Vascular Inflammation and Lung Hemorrhage in Systemic Lupus and SARS CoV2 Infection in Mouse … L Zhang, JR Yaron, L Schutz, E Aliskevich, K Browder, N Saldevar, ... Circulation 144 (Suppl_2), A13747-A13747, 2021 | | 2021 |
| Serp-1, a Myxoma Virus-Derived Immune-Modulating Protein, Demonstrates Therapeutic Benefit and Reduces Early Inflammation after Spinal Cord Injury in Rats L Schutz | | 2021 |
Jordan R YaronAssistant Professor - Arizona State UniversityVerified email at asu.edu
